Beginning a new era of precision Alzheimer’s therapeutics

The lecanemab approval last year marked what many believe is just the beginning of a new era of novel and more effective Alzheimer's therapies.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...